Design, synthesis and activity evaluation of tetrahydroisoquinoline‐based programmed cell death ligand 1 inhibitors
Smart Molecules · 28.07.2026
DOI: 10.1002/smo2.70075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Smart Molecules, online erschienen am 28.07.2026. Verfasst von Menglin Yu und 15 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Fine Chemicals Department of Pharmaceutical Engineering School of Chemical Engineering Dalian University of Technology Dalian…. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Small molecule blockade of the programmed death receptor 1 (PD‐1)/programmed cell death ligand 1 (PD‐L1) pathway represents a promising approach for tumor immunotherapy. Based on the previously developed 3D‐quantitative structure‐activity relationship pharmacophore model for PD‐L1 inhibitors, virtual screening followed by homogeneous time‐resolved fluorescence (HTRF) activity testing identified the compound {1‐[(biphenyl‐4‐yl)methyl]‐7‐methoxy‐1,2,3,4‐tetrahydroisoquinolin‐6‐yl}acetic acid methyl ester (Compound Y6 ) as a hit. Analysis of computational docking results of compound Y6 with PD‐L1 suggested targeting the methyl acetate substituent at position 6 for optimization. Guided by this, 20 new derivatives were designed and synthesized. The synthesized compounds were subjected to HTRF test and 6 compounds with significant protein blocking effects were screened for subsequent surface plasmon resonance (SPR) test. Subsequent SPR analysis confirmed strong binding of these 6 compounds to hPD‐L1 protein with K D values ranging from 0.24 to 21.31 μM. Several derivatives displayed improved or comparable PD‐L1 binding affinity relative to the lead compound Y6 ( K D = 11.3 μM). A co‐incubation system (PD‐1 + Jurkat T/PD‐L1 + HepG2) was established to evaluate functional immune restoration. This evaluation revealed that compound Y7f effectively promoted HepG2 cells death by restoring T cell immune function. MD simulations identify (1R,16R)‐Y7f as the most potent PD‐L1 dimerization inducer within the compound Y7f stereoisomer series. The results indicated that the biphenyl‐tetrahydroisoquinoline scaffold is a promising structural framework for developing novel PD‐1/PD‐L1 inhibitors and deserves further investigation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Fine Chemicals Department of Pharmaceutical Engineering School of Chemical Engineering Dalian University of Technology Dalian Liaoning China.
- Department of Central Laboratory Dalian Municipal Central Hospital Dalian Liaoning China.
- Ningbo Institute of Dalian University of Technology Ningbo China.
- Viwit Pharmaceuticals Co., Ltd Zaozhuang Shandong China.
ORCID-Profile: Shixuan Lv, Xiuhan Guo, Qingwei Meng, Yueqing Li
Zitieren
APA
Yu, M., Cai, S., Pan, Y., Wang, H., Zhang, F., Ma, A., Lv, S., Guo, X., Wang, S., Song, Q., Ma, C., Wang, S., Zhang, L., Wang, J., Meng, Q., & Li, Y. (2026). Design, synthesis and activity evaluation of tetrahydroisoquinoline‐based programmed cell death ligand 1 inhibitors. Smart Molecules. https://doi.org/10.1002/smo2.70075
Vancouver
Yu M, Cai S, Pan Y, Wang H, Zhang F, Ma A, et al. Design, synthesis and activity evaluation of tetrahydroisoquinoline‐based programmed cell death ligand 1 inhibitors. Smart Molecules. 2026. doi:10.1002/smo2.70075
BibTeX
@article{Yu2026,
author = {Yu, Menglin and Cai, Sen and Pan, Yanyan and Wang, Heshuang and Zhang, Fengwu and Ma, Aiyu and Lv, Shixuan and Guo, Xiuhan and Wang, Shisheng and Song, Qiling and Ma, Chunyan and Wang, Shuai and Zhang, Li and Wang, Jian and Meng, Qingwei and Li, Yueqing},
title = {Design, synthesis and activity evaluation of tetrahydroisoquinoline‐based programmed cell death ligand 1 inhibitors},
journal = {Smart Molecules},
year = {2026},
doi = {10.1002/smo2.70075}
}
EUVIMED